FASN and neoplasm: Given the involvement of the enzyme FASN in numerous tumor types, FASN inhibitors including C75, C93, epigallocatechin gallate, G28UCM, orlistat, Fasnall, GSK2194069, and GSK837149A have been evaluated in a mouse model of breast cancer [79].